西班牙的共识是关于在患有高氏病的妇女怀孕的管理
Enrique J Calderón1,2, Alicia Rodríguez-Fernández3, Irene Calderón-Baturone4
1Instituto de Biomedicina de Sevilla, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain. ecalderon@us.es.
Orphanet journal of rare diseases
|March 29, 2025
概括
这项研究为怀孕,分娩和哺乳期间管理高氏病提供了共识指南. 它提供基于证据的建议,以改善母亲和新生儿的健康结果.
科学领域:
- 生殖医学 生殖医学
- 遗传疾病 遗传性疾病
- 血液学 血液学 血液学
背景情况:
- 氏病会影响母亲和新生儿的怀孕,分娩和哺乳期.
- 酶替代疗法复杂化了Gaucher患者的怀孕管理.
- 由于缺乏临床试验,存在有限的确的科学证据.
研究的目的:
- 为了建立一个全面的管理指南,在怀孕期间的高希氏病.
- 为了应对怀孕前,怀孕期间和怀孕后的临床挑战.
- 为医疗保健专业人员,患者和家人提供必要的信息.
主要方法:
- 使用GRADE方法来评估科学证据的质量.
- 通过与Gaucher专家的双轮Delphi共识过程制定建议.
- 整合患者的价值观和偏好与证据一起.
主要成果:
- 为怀孕前和遗传咨询提出了九项建议.
- 制定了七项关于产后管理的建议.
- 为产后护理和母乳养制定了八项建议.
结论:
- 一份共识指南标准化了高氏病的妊娠管理.
- 该指南将最好的可用证据与专家意见相结合.
- 它是医疗保健提供者和经验有限或无法进入专门中心的患者的关键工具.
相关概念视频
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...